Distinct Roles of Estrogen Receptor-α and β in the Modulation of Vascular Inducible Nitric-Oxide Synthase in Diabetes
Authors:
- Andrea CignarellaACAndrea Cignarella
- Chiara BolegoCBChiara Bolego
- Valeria PelosiVPValeria Pelosi
- Clara MedaCMClara Meda
- Andrée KrustAKAndrée Krust
- Christian PinnaCPChristian Pinna
- Rosa Maria GaionRGRosa Maria Gaion
- Elisabetta VegetoEVElisabetta Vegeto
- Adriana MaggiAMAdriana Maggi
- 1 January 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 328 (1) , 174-182
Abstract
Estrogen is known to affect vascular function and diabetes development, but the relative contribution of estrogen receptor (ER) isoforms is unclear. The aim of this study was to determine how individual ER isoforms modulate inflammatory enzymes in the vascular wall of control and streptozotocin (STZ)-injected rodents. Primary cultures of rat aortic smooth muscle cells (SMCs) were stimulated with inflammatory agents in the presence or absence of increasing concentrations of the ERα and ERβ-selective agonists 4,4′,4′′-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) and diarylpropionitrile (DPN), respectively. The production of inducible nitric-oxide synthase (iNOS), a classical indicator of vascular inflammation, was significantly reduced by PPT in control but not diabetic SMCs, whereas it was further enhanced by DPN treatment in both groups. This distinct action profile was not related to changes in ER transcriptional activity. However, extracellular signal-regulated kinase 1/2 signaling was activated by DPN but not by PPT in cytokine-treated SMCs. In cultured aortic rings from both normoglycemic and STZ-diabetic mice, pharmacological activation of ERα attenuated cytokine-driven iNOS induction by 30 to 50%. Vascular iNOS levels were decreased consistently when adding 1 nM 17β-estradiol to aortic tissues from ERβ- but not ERα-knockout mice. These findings suggest a possible role for ERα-selective ligands in reducing vascular inflammatory responses under normo- and hyperglycemic conditions.Keywords
This publication has 45 references indexed in Scilit:
- Prolonged Ovarian Hormone Deprivation Impairs the Protective Vascular Actions of Estrogen Receptor αAgonistsHypertension, 2008
- Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase ActivityCirculation Research, 2008
- Differential Effects of 17β-Estradiol on Function and Expression of Estrogen Receptor α, Estrogen Receptor β, and GPR30 in Arteries and Veins of Patients With AtherosclerosisHypertension, 2007
- Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in miceProceedings of the National Academy of Sciences, 2006
- Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor-α in a Rodent Experimental Stroke ModelStroke, 2005
- Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vaginaInternational Journal Of Impotence Research, 2003
- Diabetes Undermines Estrogen Control of Inducible Nitric Oxide Synthase Function in Rat Aortic Smooth Muscle Cells Through Overexpression of Estrogen Receptor-βCirculation, 2003
- Combined lack of estrogen receptors a and ? affects vascular iNOS protein expressionCell and tissue research, 2003
- Branched Chain Fatty Acids Induce Nitric Oxide-dependent Apoptosis in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2002
- 17 -Estradiol Decreases Nitric Oxide Synthase II Synthesis in Vascular Smooth Muscle CellsEndocrinology, 1999